Advanced Systemic Mastocytosis
·MeSH: Mastocytosis, Systemic
Prevalence
30.0 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| blu-263 | Blueprint Medicines Corp (BPMC) |
Frequently asked questions
How many drugs are in development for Advanced Systemic Mastocytosis?
BioSniper tracks 1 drug in development for Advanced Systemic Mastocytosis across 1 company.
How many clinical trials target Advanced Systemic Mastocytosis?
There are 2 clinical trials targeting Advanced Systemic Mastocytosis tracked by BioSniper.
What is the prevalence of Advanced Systemic Mastocytosis?
The estimated prevalence of Advanced Systemic Mastocytosis is approximately 30.0 per 100,000 population.
Deep-dive into Advanced Systemic Mastocytosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis